All In Biotech

Drug Trial Radar · NCT07088159

Intermediate-size Patient Population Expanded Access Protocol

Intermediate-size Patient Population Expanded Access Protocol for Tazbentetol in Adult Patients With Amyotrophic Lateral Sclerosis (ALS)

Last checked: Nov 19, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Available

Status

Available

Enrollment

Not stated

Start

Not stated

Primary completion

Not stated

Sponsor

Lead sponsor
SpinogenixIndustry
Sponsor type
Industry
First posted
Jul 28, 2025

More drug trials from this sponsor

Design

Study type
Expanded access
Who can join
All sexes, from 18 years, up to 85 years

Summary

As written by the sponsor on the registry.

The purpose of this Expanded Access Program is to provide tazbentetol to ALS patients who are not eligible to enroll in an ALS clinical trial. This Expanded Access Program will assess safety and tolerability, and clinical efficacy of tazbentelol.

Conditions

  • ALS (Amyotrophic Lateral Sclerosis)

Interventions

  • TazbentetolDrug

    300 mg Tazbentetol will taken by mouth once daily.

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

16 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama Birmingham

    Birmingham, Alabama · Available

  • Mayo Scottsdale

    Scottsdale, Arizona · Available

  • Kaiser Permanente Los Angeles

    Los Angeles, California · Available

  • Cedar-Sinai Medical Center

    Los Angeles, California · Available

  • California Pacific Medical Center

    San Francisco, California · Available

  • Nova Southeastern University

    Davie, Florida · Available

  • Synapticure

    Chicago, Illinois · Available

  • University of Kansas Medical Center

    Kansas City, Kansas · Available

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire · Available

  • Atlantic Health

    Summit, New Jersey · Available

  • New Mexico VA Health Care System

    Albuquerque, New Mexico · Available

  • NYU Langone Health

    New York, New York · Available

  • Columbia University Medical Center

    New York, New York · Available

  • Thomas Jefferson University

    Philadelphia, Pennsylvania · Available

  • Baylor College of Medicine

    Houston, Texas · Available

  • VCU ALS Research Group

    Henrico, Virginia · Available

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.